Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
BHP Seeks Extension For Takeover; GoldMining Begins São Jorge Drilling; Ivanhoe Electric Advances Copper Project And More: Wednesday's Top Mining Stories
BHP partners with Ivanhoe Electric to explore critical minerals in the US. Joint venture focuses on copper exploration in key states. Typhoon system used for precise geophysical survey.
BHP's subsidiary signed Exploration Alliance Agreement with Ivanhoe Electric to explore for copper and other minerals in the US, with a mutual goal of finding new sources for the growing demand. BHP will provide $15M initial funding, with potential for more on a 50/50 basis.
Quarterly results for Ivanhoe Electric and Saudi Arabian Mining Company Ma'aden's joint venture, Metallus' sustainability efforts, ArcelorMittal's safety audit, and an analyst's update on Gatos Silver.
Top stories: Barrick Gold expands in Peru, Foremost advances lithium project, Nexa Resources concludes tender offer, Ivanhoe hires VP for health and safety.
Nippon Steel commits $1.4B for US Steel acquisition, Ivanhoe Electric finds significant copper, iron ore prices increase due to China's industrial recovery, Reliance, Inc. acquires Mid-West Materials
U.S. gov't selects Century Aluminum for $500M funding, Cleveland-Cliffs for $575M to decarbonize, Newmont sells Ghana gold mine, Ivanhoe secures stake in $338M project.
Advancements in Ivanhoe Electric's proprietary software for interpreting Typhoon data, President Biden's opposition to Nippon Steel's acquisition of U.S. Steel, and Hycroft Mining's high-grade silver discoveries and exploration advancements highlighted in their full-year 2023 results.
Top Stories for Jan. 8, 2024: 1. Freeport-McMoRan Inc. (NYSEFCX) was upgraded from Market Perform to Outperform, with its price target raised from $41 to $48.50 by an analyst at Bernstein.
Gainers First Wave BioPharma, Inc. (NASDAQFWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi.
